📰 Simcere Pharma News
Simcere Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Simcere Pharma. Real-time updates on events, politics, business and more.
November 21, 2022
Shanghai Fosun Pharma announced it has licensed US rights to a PD-1 candidate from its longstanding partner Henlius Biotech in an $840 million agreement. Read more here...
October 3, 2022
Beijing YishengBio will merge with SPAC vehicle Summit Healthcare Acquisition to list on Nasdaq. Sihuan Pharma subsidiary Xuanzhu Biopharm has filed for an IPO on the Shanghai STAR Exchange.
July 24, 2022
Frontera Therapeutics completed a $160 million Series B funding to support its AAV programs.